Kaczynski Jerzy, Hansson Göran, Wallerstedt Sven
Department of Medicine, Göteborg University, Sahlgren's University Hospital, Sweden.
Hepatogastroenterology. 2005 Nov-Dec;52(66):1798-802.
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) had been one of the malignancies with the highest reported increase of incidence in Sweden, but during the late 20-year period the incidence has been decreasing. The aims of our study were to state the impact of autopsy on diagnosis and to identify clinical characteristics in HCC.
This retrospective study was performed in Göteborg, Sweden and included all cases with a diagnosis of liver cancer from a period with a high autopsy frequency (1958-1979). The cases were reevaluated histopathologically and the autopsy records as well as the case files were scrutinized.
The majority (63%) of the 530 biopsy verified cases of HCC were diagnosed unexpectedly at autopsy. Cirrhosis of the liver could be established in 71% of the cases, but was diagnosed or at least clinically suspected before the diagnosis of the tumor only in a minority (19%) of all HCC patients. At presentation, malaise (85%), weight loss (78%), anorexia (67%) and hepatomegaly (84%) were common. The median survival time from diagnosis was one month. In most cases (92%) the cause of death was either directly or indirectly related to HCC and/or underlying liver disease such as advanced tumor disease, hepatic failure and gastrointestinal bleeding. Spontaneous rupture of HCC was the cause of death in 17 cases (3%)
In an unselected population in a low incidence area of HCC, most patients have clinically unknown cirrhosis of the liver and present with vague general paramalignant symptoms. HCC has an extremely poor prognosis. Since HCC, in a majority of cases, remains undiagnosed before death, the autopsy has great impact on the diagnosis. This should be considered in interpretation of results from epidemiological studies.
背景/目的:肝细胞癌(HCC)曾是瑞典报告发病率增长最高的恶性肿瘤之一,但在过去20年后期发病率一直在下降。我们研究的目的是阐明尸检对诊断的影响,并确定HCC的临床特征。
这项回顾性研究在瑞典哥德堡进行,纳入了尸检频率较高时期(1958 - 1979年)所有诊断为肝癌的病例。对这些病例进行了组织病理学重新评估,并仔细审查了尸检记录和病例档案。
530例经活检证实的HCC病例中,大多数(63%)是在尸检时意外诊断出来的。71%的病例可诊断为肝硬化,但仅在所有HCC患者中的少数(19%)在肿瘤诊断之前被诊断出或至少临床上怀疑有肝硬化。就诊时,不适(85%)、体重减轻(78%)、厌食(67%)和肝肿大(84%)很常见。从诊断开始的中位生存时间为1个月。在大多数病例(92%)中,死亡原因直接或间接与HCC和/或潜在肝脏疾病有关,如晚期肿瘤疾病、肝衰竭和胃肠道出血。HCC自发破裂是17例(3%)的死亡原因。
在HCC低发病率地区的未选择人群中,大多数患者临床上患有未知的肝硬化,并表现出模糊的全身类癌症状。HCC预后极差。由于在大多数情况下,HCC在死亡前仍未被诊断出来,尸检对诊断有很大影响。在解释流行病学研究结果时应考虑到这一点。